Abstract
An open randomized comparative study was conducted to evaluate the efficacy of Cefepime (2 gm iv. 8 hr.) vs. ceftazidime (2 gm iv. every 8 hr.) in empirical therapy of febrile neutropenic patients. A total of 40 eligible febrile episodes were randomized to be treated with study regimen. Twenty febrile episodes were treated with cefepime and 20 were treated with ceftazidime. The two groups were comparable in terms of age, sex, height, underlying neoplasm, number of pretherapy neutrophils, duration of neutropenia. The overall therapeutic success rate of cetepime group (60%) was comparable to that of ceftazidime group (55%). The results of this study suggest that cefepime is an effective and safe agent in empirical therapy of febrile episode in neutropenic patient and its efficacy is comparable with that of ceftazidime.
Similar content being viewed by others
References
Bergumans T, Scolier SP (2002) Myelosuppression and infective complications. In: Souhami RL, Tannok I, Hohznberger P, Horiot SC, editors. Oxford Textbook of oncology. 2nd edn. Oxford University Press Inc., New York; Vol. 1: pp. 575–89
Finberg R (2005) Infections in patients with cancer. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principles of Internal Medicine. Vol.1, 16th edn. New York: McGraw Hill; p 489–496
Fu Der Wang, Cheng Y Liu, Hui Chi Hsu, Iyh Pyng Gau, Wing Keung Chan, Ming Li Haung (1999) A comparative study of Cefepime versus Ceftezadime as empirical therapy in febrile neutropenic patients. Chemotherapy 45:370–379
Jandula B, Martino R, Gurgi M, Manteiga R, Sierra J (2001) Treatment of febrile neutropenia with cefepime monotherapy. Chemotherapy 47:226–231
Kebudi R, Gorgun O, Ayan I, Gurler N, Akici F, Toreci K (2001) Randomized comparison of cefepime versus Ceftezadime monotherapy for fever and neutropenia in children with solid tumours. Med Pediatr Oncol 36(4):434–441
Cordonniek C, Herbrecht R, Pico JL (1997) Cefepime / Amikacin versus Ceftazidime / Amikacin as empirical therapy for febrile episodes in neutropenic patients. A comparative study. The French Cefepime Study Group. Gun lnf Dis 24:41–51
Chandrasekhar PH, Arrow PM Cefepime versus Ceftezadime as empirical therapy for fever in neutropenic patients with cancer. Annals of Pharmacotherapy 34(9):989–995
Motalar J, Segura A, Bosch C, Galan A, Juano, Molins C et al (2002) Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia. Med Oncol 19(3): 161–166
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghalaut, P.S., Chaudhry, U., Ghalaut, V.S. et al. Cefepime versus ceftazidime as empirical therapy for fever in neutropenic patients with haematological malignancies. Indian J Hematol Blood Transfus 23, 104–106 (2007). https://doi.org/10.1007/s12288-008-0007-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-008-0007-x